Harmony Biosciences
-
Plymouth Meeting Pharmaceutical Company Eyes $1B Milestone
Harmony Biosciences says its flagship narcolepsy drug is on track to hit a major milestone, writes John George for The Philadelphia Business Journal. The Plymouth…
-
Plymouth Meeting’s Harmony Biosciences Holdings Acquires Zynerba Pharmaceuticals
Harmony Biosciences Holdings in Plymouth Meeting has agreed to buy Zynerba Pharmaceuticals for up to $200 million, writes John George for Philadelphia Business Journal. Under…
-
These Two Montco-Based Companies Awarded for ‘Driving the Region’s Innovation Scene Forward’
Two Montgomery County companies are among the winners of the inaugural Fire Awards presented by The Philadelphia Business Journal, writes Lisa Dukart for the publication.…
Founding Partners
Advertisement
Affiliate Partners
